DIMA Biotechnology Ltd

DiMPro™ Membrane Protein Platform

DiMPro excels in the expression and purification of membrane proteins using mammalian cells, displaying an inventory of over 1,000 functional proteins. Additionally, 200+ active full-length multi-pass membrane proteins, with a particular focus on challenging targets such as G protein-coupled receptors (GPCRs) and ion channels.

DimAb® Single B-Cell Antibody Discovery Platform
The DimAb® B cell library empowers customers to access an extensive pool of over 10,000 positive hits within only a month. This accelerated timeline ensures that researchers can efficiently explore and identify potential candidates, significantly advancing the process of discovering and characterising antibodies with high specificity and functionality.  

DiLibrary™ Mammalian Display Antibody Engineering Platform

DIMA’s proprietary platform stands out in the fields of antibody humanisation, affinity maturation, and other engineering applications. Antibodies engineered using this system demonstrate unparalleled developability, outperforming those generated by traditional phage or yeast display platforms.

DiAssay™ Antibody Evaluation Platform


DIMA directs a comprehensive suite of screening processes tailored to assist drug developers in pinpointing the optimal hit molecules for their specific antibody drug modalities. DIMA's expertise extends to three specialised platforms designed for Bispecific Antibodies (BsAbs). Antibodies-Drug Conjugates (ADCs), and Chimeric Antigen Receptor T-cell Therapies (CAR-T).